糖尿病与心血管疾病

1. Coutinho K.Gerstein HC.WANG Y The relationship between glucose and incident cardiovascular events:a metaregression analysis of published data of 20 studies of 95,783 individuals followed for 12.4 years 1999(2)
2. Standl E.Balletshofer B.Dahl B Predictors of 10-year macrovascular and overall mortality in patients with NIDDM:the munich general practioner project 1996(12)
3. UK prospective diabetes study(UKPDS The effect of inensiveblood-glucose control with meformin on complications in overweith patients with type 2 diabetes(UKPDS 34) 1998
4. Malmberg K Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus.DIGAMI(Diabetes Mellitus,Insulin Glucose Infusion in Acute Myocardial Infarction)Study Group 1997
5. Isomaa B.Almgren P.Tuomi T Cardiovascular morbidity and mortality associated with the metabolic syndrome 2001(4)
6. Minamikawa J.Tanaka S.Yamauchi M Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes 1998(5)
7. Isles CG.Paterson JR Identifying patients at risk for coronary heart disease:implications from trials of lipid-lowering drug therapy 2000(9)
8. Pyrorala K.Pedersen TR.Kjehshus J Cholesterol lowering with Simvastatin improves prognosis of diabetic patients with coronary heart disease:A subgroup analysis of the Scandinavian Simvastatin Survival Study(4S) 1997(4)
9. Goldberg RB.Mellies MJ.Sacks FM Cardiovascular events and their reduction with pravastatin in diabetic and glucose-tolerant myocardial infarction survivors with average cholesterol levels:subgroup analyses in the cholesterol and recurrent events (CARE) trial 1998(23)
10. Hansson L.Zanchetti A.Carruthers SG Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:pricipal results of the Hypertensive Optimal Treatment(HOT)randomised trial 1998
11. Estacio RO.Jeffers BW.Hiatt WR The effect of nisoldipine as compared with analapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension 1998(10)
12. Tatti P.Pahor M.Byington RB Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial(FACET)in patients with hypertension and NIDDM 1998(4)
13. Tuomilehto J.Rastenyte D.Birkenhager W Effects of calcium-channel blocker in older patients with diabetes and systolic hypertension.Systolic hypertension in Europe Trial Investigators 1999(9)
14. Halimi JM.Forhan A.Balkau B Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women 2001(8)
15. Schultz CJ.Neil HA.Dalton RN Blood pressure dose not rise before the onset of microalbuminyria in children followed from diagnosis of type 1 diabetes.Oxford Regional Prospective Stive Study Group 2001(3)
16. Orth SR Smoking-a renal risk factor 2000(1)
17. Muhr-Becker D.Ziegler AG.Druschky A Evidence for specific autoimmunity against sympathetic and parasympathetic nervous tissues in type 1 diabetes mellitus and the relation to cardiac autonomic dysfunction 1998(6)
18. Schnell O.Schwarz A.Muhe-Becker D Autoantibodies against autonomic nerves tissues in type 2 diabetes mellitus:no association with cardic antonomic dysfunction 2000(3)
19. American Diabetes Association:Aspirin Therapy in Diabetes 1997(11)
20. Gustafsson I.Hildebrandt P Early failure of diabetes heart 2001(1)
21. Poirier P.Bogaty P.Garneau Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes 2001(1)
22. Standl E.Schnell O A look at the heart in diabetes mellitus:from ailing to falling 2000(12)

更多...